BOOTH #1405

Looking for a way to improve the limit of detection for low-frequency CNVs and mutations?

Explore NuProbe’s technologies for oncology translational research and development at AMP 2022 Annual Meeting & Expo – proprietary technologies to enable ultrasensitive detection while overcoming the challenges of current methods.

Emerging Solutions for Non-Invasive Cancer Monitoring

This talk will discuss the current state, advantages, and limitations of non-invasive liquid biopsies in oncology. We will also introduce Blocker Displacement Amplification and Quantitative Amplicon Sequencing technologies and discuss how these technologies can improve liquid biopsies while highlighting applications of these technologies in non-invasive longitudinal monitoring.

Connect With Us


    Nick Gallerani, Ph.D.

    Nicholas Gallerani, Ph.D., serves as a Senior Business Development Associate at NuProbe. Prior to joining NuProbe, he received his Ph.D. in Pathobiology and Molecular Medicine from Columbia University and was a Fellow at Columbia Technology Ventures, where he assessed new technologies generated by their research labs.